Research programme: leukotriene antagonists - VUFBAlternative Names: 19354; 20076; 20556; Leukotriene antagonists research programme - VUFB; VUFB 19354; VUFB 20076; VUFB 20556
Latest Information Update: 14 Apr 2010
At a glance
- Originator VUFB
- Class Quinolines
- Mechanism of Action Leukotriene B4 receptor antagonists; Leukotriene D4 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 29 Sep 2004 Preclinical trials in Asthma in Czech Republic (unspecified route)